PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
|Effective start/end date||9/30/13 → 6/30/20|
- JOSLIN DIABETES CENTER, INC.
- NATIONAL INSTITUTES OF HEALTH (NIH)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.